These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10167067)

  • 21. Health technology assessment in Canada: diversity and evolution.
    Hailey DM
    Med J Aust; 2007 Sep; 187(5):286-8. PubMed ID: 17767434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The political dimension in health care technology assessment programs.
    Banta HD; Andreasen PB
    Int J Technol Assess Health Care; 1990; 6(1):115-23. PubMed ID: 2361816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation and health care decision-making.
    Rutten F
    Health Policy; 1996 Jun; 36(3):215-29. PubMed ID: 10158267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care technology assessment: implications for modern medical practice. Part II. Decision making on technology adoption.
    Pierce RG; Bozic KJ; Hall BL; Breivis J
    Am J Orthop (Belle Mead NJ); 2007 Feb; 36(2):71-6. PubMed ID: 17405635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges ahead for federal technology assessment.
    Neumann PJ
    Health Aff (Millwood); 2007; 26(2):w150-2. PubMed ID: 17259197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology.
    Davies L; Coyle D; Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1601-7. PubMed ID: 8047917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic evaluation for pharmaceuticals in Germany.
    Jönsson B
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S1-2. PubMed ID: 17638033
    [No Abstract]   [Full Text] [Related]  

  • 29. Three meanings of capacity; or, why the federal government is most likely to lead on insurance access issues.
    White J
    J Health Polit Policy Law; 2003; 28(2-3):217-44. PubMed ID: 12836884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding Health Technology Assessments to Include Effects on the Environment.
    Marsh K; Ganz ML; Hsu J; Strandberg-Larsen M; Gonzalez RP; Lund N
    Value Health; 2016; 19(2):249-54. PubMed ID: 27021760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health technology assessment, value-based decision making, and innovation.
    Henshall C; Schuller T;
    Int J Technol Assess Health Care; 2013 Oct; 29(4):353-9. PubMed ID: 23845404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of quantitative policy analysis in HIV prevention technology transfer.
    Holtgrave DR
    Public Health Rep; 2004; 119(1):19-22. PubMed ID: 15147644
    [No Abstract]   [Full Text] [Related]  

  • 33. Medical technology meets managed competition.
    Durenberger D; Foote SB
    J Am Health Policy; 1993; 3(3):23-8. PubMed ID: 10125731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for successful evaluation and policy-making toward health care technology on the move: the case of medical lasers.
    Banta HD; Vondeling H
    Soc Sci Med; 1994 Jun; 38(12):1663-74. PubMed ID: 8047925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A regulatory governance perspective on health technology assessment (HTA) in France: the contextual mediation of common functional pressures.
    Barron AJ; Klinger C; Shah SM; Wright JS
    Health Policy; 2015 Feb; 119(2):137-46. PubMed ID: 25458970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of health technology: economic issues for health policy and policy issues for economic appraisal.
    Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1593-600. PubMed ID: 8047916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BioChannel 2004. 2 December 2004, Ashford, UK.
    Worker C
    IDrugs; 2005 Feb; 8(2):115-7. PubMed ID: 15696411
    [No Abstract]   [Full Text] [Related]  

  • 39. Review of medical technology policies shows need, opportunities for changes.
    Banta D
    Hospitals; 1982 Apr; 56(7):87-90. PubMed ID: 6800914
    [No Abstract]   [Full Text] [Related]  

  • 40. Developing a decision support system to link health technology assessment (HTA) reports to the health system policies in Iran.
    Yazdani S; Jadidfard MP
    Health Policy Plan; 2017 May; 32(4):504-515. PubMed ID: 28025325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.